Depression May Worsen Obesity.
New study provides more evidence of a identify with between depression and extra pounds around the waist, although it's not exactly clear how they're connected. The mull over raises the possibility that depression causes people to put on extra pounds around the belly. The antithesis doesn't appear to be the case: researchers found that overweight people aren't more likely to become depressed than their normal-weight peers.
These findings come from researchers at the University of Alabama at Birmingham, who examined evidence from the Coronary Artery Risk Development in Young Adults Study (CARDIA), a 20-year longitudinal swat of more than 5100 men and women old 18-30. Longitudinal studies look for a link between cause and effect by observing a association of individuals at regular intervals over a long period of time.
Showing posts with label pounds. Show all posts
Showing posts with label pounds. Show all posts
Sunday, 29 December 2019
Tuesday, 24 January 2017
The Main Cause Of Obesity In The USA Are Sugary Drinks, French Fries, Potato Chips, Red Meat
The Main Cause Of Obesity In The USA Are Sugary Drinks, French Fries, Potato Chips, Red Meat.
The edict to feed-bag less and use more is far from far-reaching, as a additional analysis points to the increased consumption of potato chips, French fries, sugary sodas and red victuals as a major cause of weight gain in plebeians across the United States. Inadequate changes in lifestyle factors such as television watching, exert and sleep were also linked to gradual but relentless weight gain across the board. Data from three take studies following more than 120000 healthy, non-obese American women and men for up to 20 years found that participants gained an ordinary of 3,35 pounds within each four-year period - totaling more than 16 pounds over two decades.
The unrelenting value gain was tied most strongly to eating potatoes, sugar-sweetened beverages, red and processed meats and ladylike grains such as white flour. "This is the paunchiness epidemic before our eyes," said study author Dr Dariush Mozaffarian, an companion professor in the department of epidemiology at Harvard School of Public Health and the division of cardiovascular pharmaceutical at Brigham and Women's Hospital and Harvard Medical School.
So "It's not a small segment of the inhabitants gaining an enormous amount of weight quickly; it's everyone gaining weight slowly. I was surprised how steadfast the results were, down to the size of the effect and direction of the effect". The mug up is published in the June 23, 2011 issue of the New England Journal of Medicine.
Participants included 50422 women in the Nurses' Health Study, followed from 1986 to 2006; 47898 women in the Nurses' Health Study II, followed from 1991 to 2003; and 22,557 men in the Health Professionals Follow-Up Study, tracked from 1986 to 2006. The researchers assessed unfettered relationships between changes in lifestyle behaviors and charge changes within four-year periods, also judgement that those doing more material motion translated into 1,76 fewer pounds gained during each time period.
Participants who slept less than six hours or more than eight hours per end of day also gained more within each study period, as did those who watched more television an standard of 0,31 pounds for every hour of TV watched per day. And fast scoff addicts, beware: Each increased daily serving of potato chips alone was associated with a 1,69 pound-weight pull away every four years.
The edict to feed-bag less and use more is far from far-reaching, as a additional analysis points to the increased consumption of potato chips, French fries, sugary sodas and red victuals as a major cause of weight gain in plebeians across the United States. Inadequate changes in lifestyle factors such as television watching, exert and sleep were also linked to gradual but relentless weight gain across the board. Data from three take studies following more than 120000 healthy, non-obese American women and men for up to 20 years found that participants gained an ordinary of 3,35 pounds within each four-year period - totaling more than 16 pounds over two decades.
The unrelenting value gain was tied most strongly to eating potatoes, sugar-sweetened beverages, red and processed meats and ladylike grains such as white flour. "This is the paunchiness epidemic before our eyes," said study author Dr Dariush Mozaffarian, an companion professor in the department of epidemiology at Harvard School of Public Health and the division of cardiovascular pharmaceutical at Brigham and Women's Hospital and Harvard Medical School.
So "It's not a small segment of the inhabitants gaining an enormous amount of weight quickly; it's everyone gaining weight slowly. I was surprised how steadfast the results were, down to the size of the effect and direction of the effect". The mug up is published in the June 23, 2011 issue of the New England Journal of Medicine.
Participants included 50422 women in the Nurses' Health Study, followed from 1986 to 2006; 47898 women in the Nurses' Health Study II, followed from 1991 to 2003; and 22,557 men in the Health Professionals Follow-Up Study, tracked from 1986 to 2006. The researchers assessed unfettered relationships between changes in lifestyle behaviors and charge changes within four-year periods, also judgement that those doing more material motion translated into 1,76 fewer pounds gained during each time period.
Participants who slept less than six hours or more than eight hours per end of day also gained more within each study period, as did those who watched more television an standard of 0,31 pounds for every hour of TV watched per day. And fast scoff addicts, beware: Each increased daily serving of potato chips alone was associated with a 1,69 pound-weight pull away every four years.
Friday, 19 February 2016
The Normalization Of Weight A Woman After Childbirth Reduces The Risk Of Developing Diabetes
The Normalization Of Weight A Woman After Childbirth Reduces The Risk Of Developing Diabetes.
Women who gained 18 or more pounds after their start newborn was born are more than three times more undoubtedly to develop gestational diabetes during their second pregnancy, according to rejuvenated research. On the bright side, the study, published in the May 23 online printing of Obstetrics & Gynecology, also found that women who were able to shed six or more pounds between babies reduced their risk of the condition by 50 percent. Gestational diabetes, a condition that occurs during pregnancy, can cause honest complications in the final weeks of pregnancy, birth and right after a baby is born.
Research shows that women who have had the get during one pregnancy have a greater chance of developing the condition again. Excess weight profit before or during pregnancy also boosts a woman's risk. But women who trim extra pounds after the nativity of a baby could significantly reduce their risk of developing gestational diabetes in a subsequent pregnancy.
Women who gained 18 or more pounds after their start newborn was born are more than three times more undoubtedly to develop gestational diabetes during their second pregnancy, according to rejuvenated research. On the bright side, the study, published in the May 23 online printing of Obstetrics & Gynecology, also found that women who were able to shed six or more pounds between babies reduced their risk of the condition by 50 percent. Gestational diabetes, a condition that occurs during pregnancy, can cause honest complications in the final weeks of pregnancy, birth and right after a baby is born.
Research shows that women who have had the get during one pregnancy have a greater chance of developing the condition again. Excess weight profit before or during pregnancy also boosts a woman's risk. But women who trim extra pounds after the nativity of a baby could significantly reduce their risk of developing gestational diabetes in a subsequent pregnancy.
Thursday, 15 August 2013
The Rapid Decrease In Obesity Facilitates To The Duration Of The Weight Loss
The Rapid Decrease In Obesity Facilitates To The Duration Of The Weight Loss.
When it comes to weight-loss patterns, the valued adage proclaims that "slow and steady" wins the race, but just out enquiry suggests otherwise. A novel office found that obese women who started out losing 1,5 pounds a week or more on norm and kept it up wrecked more weight over time than women who lost more slowly antehealth.com. They also maintained the sacrifice longer and were no more likely to put it back on than the slowest losers, the researchers added.
The results shouldn't be interpreted to imply that explode diets work, said study author Lisa Nackers, a doctoral apprentice in clinical psychology at the University of Florida, Gainesville. Her information is published online in the International Journal of Behavioral Medicine. Rather, she said, the quicker incline damage of the fast-losing group reflected their commitment to the program, Nackers said. "The right group attended more sessions to presentation about weight loss , completed more food records and ate fewer calories than the dumb group".
Fast loss is relative. For her study, Nackers said, "fast losers are those who bygone at least a pulsate and a half a week". The faster drubbing resulted from their active participation in the program, she said. "Those who affirm the behavior changes early do better in terms of albatross loss and long term in keeping it off".
When it comes to weight-loss patterns, the valued adage proclaims that "slow and steady" wins the race, but just out enquiry suggests otherwise. A novel office found that obese women who started out losing 1,5 pounds a week or more on norm and kept it up wrecked more weight over time than women who lost more slowly antehealth.com. They also maintained the sacrifice longer and were no more likely to put it back on than the slowest losers, the researchers added.
The results shouldn't be interpreted to imply that explode diets work, said study author Lisa Nackers, a doctoral apprentice in clinical psychology at the University of Florida, Gainesville. Her information is published online in the International Journal of Behavioral Medicine. Rather, she said, the quicker incline damage of the fast-losing group reflected their commitment to the program, Nackers said. "The right group attended more sessions to presentation about weight loss , completed more food records and ate fewer calories than the dumb group".
Fast loss is relative. For her study, Nackers said, "fast losers are those who bygone at least a pulsate and a half a week". The faster drubbing resulted from their active participation in the program, she said. "Those who affirm the behavior changes early do better in terms of albatross loss and long term in keeping it off".
Monday, 22 July 2013
Dapagliflozin Is A New Drug For The Treatment Of Type Two Diabetes
Dapagliflozin Is A New Drug For The Treatment Of Type Two Diabetes.
A unexplored drug, the essential in its class, gives added blood sugar device to living souls with type 2 diabetes who are already fascinating the glucose-lowering medication metformin. The new agent, dapagliflozin, which also helped patients elude weight, is novel in that it does not position directly on the body's insulin mechanisms, according to a study appearing in the June 26 son of The Lancet and slated for presentation at the annual engagement of the American Diabetes Association (ADA) in Orlando wheretobuyrx. "It will perhaps be used as an add-on therapy," said bookwork lead author Clifford Bailey, a chemical pathologist and professor of clinical information at Aston University in Birmingham, UK "If you don't undoubtedly get to target with the first therapy tried , this closer would offer you an opportunity hopefully to maintain improved control".
Bailey, who could not augur if or when the drug might get final approval from numb regulatory authorities, also pointed out that dapagliflozin is flexible, meaning it can be employed with various other treatments and at more or less any stage in the disease. "It's a good add-on," agreed Dr Stanley Mirsky, associated clinical professor of metabolic diseases at Mount Sinai Medical Center in New York City. "Is it a awe drug? No. It may disport a shallow role".
The study was funded by Bristol-Myers Squibb and AstraZeneca, which are developing dapagliflozin together. Dapagliflozin factory by thought-provoking the kidneys to eliminate more glucose from the body via urine. In this consider of 534 adult patients with type 2 diabetes who were already prepossessing metformin, the highest dose of dapagliflozin (10 milligrams daily) was associated with a 0,84 percent subsidence in HbA1c levels.
HbA1c is a metre of blood sugar control over time. Participants engaging 5 mg of the drug saw a 0,70 percent dwindling in HbA1c levels, while those taking 2.5 mg had a 0,67 percent decrease. In the placebo group, the subside in HbA1c was 0,3 percent, the scrutiny found.
A unexplored drug, the essential in its class, gives added blood sugar device to living souls with type 2 diabetes who are already fascinating the glucose-lowering medication metformin. The new agent, dapagliflozin, which also helped patients elude weight, is novel in that it does not position directly on the body's insulin mechanisms, according to a study appearing in the June 26 son of The Lancet and slated for presentation at the annual engagement of the American Diabetes Association (ADA) in Orlando wheretobuyrx. "It will perhaps be used as an add-on therapy," said bookwork lead author Clifford Bailey, a chemical pathologist and professor of clinical information at Aston University in Birmingham, UK "If you don't undoubtedly get to target with the first therapy tried , this closer would offer you an opportunity hopefully to maintain improved control".
Bailey, who could not augur if or when the drug might get final approval from numb regulatory authorities, also pointed out that dapagliflozin is flexible, meaning it can be employed with various other treatments and at more or less any stage in the disease. "It's a good add-on," agreed Dr Stanley Mirsky, associated clinical professor of metabolic diseases at Mount Sinai Medical Center in New York City. "Is it a awe drug? No. It may disport a shallow role".
The study was funded by Bristol-Myers Squibb and AstraZeneca, which are developing dapagliflozin together. Dapagliflozin factory by thought-provoking the kidneys to eliminate more glucose from the body via urine. In this consider of 534 adult patients with type 2 diabetes who were already prepossessing metformin, the highest dose of dapagliflozin (10 milligrams daily) was associated with a 0,84 percent subsidence in HbA1c levels.
HbA1c is a metre of blood sugar control over time. Participants engaging 5 mg of the drug saw a 0,70 percent dwindling in HbA1c levels, while those taking 2.5 mg had a 0,67 percent decrease. In the placebo group, the subside in HbA1c was 0,3 percent, the scrutiny found.
Subscribe to:
Posts (Atom)